US Stock MarketDetailed Quotes

KNSA Kiniksa Pharmaceuticals

Watchlist

17.610
-0.250-1.40%

Close Apr 25 16:00 ET

1.25BMarket Cap135.46P/E (TTM)

Kiniksa Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

65.18%79.86M

22.74%270.26M

34.76%83.4M

-32.37%67.05M

164.99%71.47M

50.19%48.35M

471.24%220.18M

230.14%61.88M

719.64%99.14M

250.10%26.97M

Operating revenue

65.18%79.86M

22.74%270.26M

34.76%83.4M

-32.37%67.05M

164.99%71.47M

50.19%48.35M

471.24%220.18M

230.14%61.88M

719.64%99.14M

250.10%26.97M

Cost of revenue

104.80%31.38M

45.91%33.41M

-204.92%-30M

128.37%26.4M

149.22%21.69M

22.86%15.32M

151.59%22.9M

-354.43%-9.84M

317.78%11.56M

252.84%8.7M

Gross profit

46.80%48.47M

20.06%236.85M

58.10%113.4M

-53.59%40.65M

172.50%49.79M

67.48%33.02M

570.03%197.29M

382.07%71.72M

838.84%87.58M

248.82%18.27M

Operating expense

47.04%65.02M

39.75%262.05M

72.54%113.32M

25.30%51.57M

40.66%52.94M

2.75%44.22M

0.77%187.51M

28.75%65.68M

2.92%41.16M

-17.81%37.64M

Selling and administrative expenses

33.18%38.68M

32.13%129.43M

35.00%36.74M

39.68%34.47M

22.37%29.18M

30.73%29.05M

13.97%97.95M

19.67%27.22M

18.87%24.68M

9.12%23.84M

Research and development costs

73.57%26.33M

16.20%76.1M

39.35%20.05M

3.77%17.11M

72.25%23.77M

-27.12%15.17M

-34.05%65.49M

-47.54%14.39M

-14.30%16.49M

-42.38%13.8M

Other operating expenses

----

134.82%56.52M

----

2,782.75%24.07M

----

Operating profit

-47.75%-16.54M

-357.81%-25.2M

-98.66%81K

-123.54%-10.93M

83.72%-3.15M

51.99%-11.2M

106.24%9.77M

116.74%6.05M

251.35%46.41M

52.24%-19.37M

Net non-operating interest income expense

Other net income (expense)

23.69%2.27M

581.88%8.54M

198.36%2.37M

654.04%2.43M

1,759.22%1.92M

5,288.24%1.83M

1,191.75%1.25M

794K

322K

103K

Other non- operating income (expenses)

23.69%2.27M

581.88%8.54M

198.36%2.37M

654.04%2.43M

1,759.22%1.92M

5,288.24%1.83M

1,191.75%1.25M

--794K

--322K

--103K

Income before tax

-52.46%-14.28M

-251.02%-16.65M

-64.19%2.45M

-118.19%-8.5M

93.57%-1.24M

59.79%-9.36M

107.04%11.03M

118.97%6.84M

252.42%46.74M

52.49%-19.27M

Income tax

17.96%3.43M

82.17%-30.74M

-1,057.44%-22.79M

103.02%5.36M

-2,364.11%-16.21M

50.96%2.91M

-12,543.10%-172.34M

753.05%2.38M

-150,203.39%-177.36M

-29.39%716K

Net income

-44.29%-17.7M

-92.32%14.08M

465.73%25.24M

-106.18%-13.86M

174.93%14.97M

51.33%-12.27M

216.11%183.36M

112.28%4.46M

833.67%224.09M

51.93%-19.98M

Net income continuous Operations

-44.29%-17.7M

-92.32%14.08M

465.73%25.24M

-106.18%-13.86M

174.93%14.97M

51.33%-12.27M

216.11%183.36M

112.28%4.46M

833.67%224.09M

51.93%-19.98M

Minority interest income

Net income attributable to the parent company

-44.29%-17.7M

-92.32%14.08M

465.73%25.24M

-106.18%-13.86M

174.93%14.97M

51.33%-12.27M

216.11%183.36M

112.28%4.46M

833.67%224.09M

51.93%-19.98M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-44.29%-17.7M

-92.32%14.08M

465.73%25.24M

-106.18%-13.86M

174.93%14.97M

51.33%-12.27M

216.11%183.36M

112.28%4.46M

833.67%224.09M

51.93%-19.98M

Basic earnings per share

-38.89%-0.25

-92.42%0.2

500.00%0.36

-106.19%-0.2

172.41%0.21

50.00%-0.18

214.78%2.64

111.32%0.06

834.09%3.23

52.46%-0.29

Diluted earnings per share

-38.89%-0.25

-92.31%0.2

483.33%0.35

-106.29%-0.2

172.41%0.21

50.00%-0.18

213.04%2.6

111.32%0.06

822.73%3.18

52.46%-0.29

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	65.18%79.86M	22.74%270.26M	34.76%83.4M	-32.37%67.05M	164.99%71.47M	50.19%48.35M	471.24%220.18M	230.14%61.88M	719.64%99.14M	250.10%26.97M
Operating revenue	65.18%79.86M	22.74%270.26M	34.76%83.4M	-32.37%67.05M	164.99%71.47M	50.19%48.35M	471.24%220.18M	230.14%61.88M	719.64%99.14M	250.10%26.97M
Cost of revenue	104.80%31.38M	45.91%33.41M	-204.92%-30M	128.37%26.4M	149.22%21.69M	22.86%15.32M	151.59%22.9M	-354.43%-9.84M	317.78%11.56M	252.84%8.7M
Gross profit	46.80%48.47M	20.06%236.85M	58.10%113.4M	-53.59%40.65M	172.50%49.79M	67.48%33.02M	570.03%197.29M	382.07%71.72M	838.84%87.58M	248.82%18.27M
Operating expense	47.04%65.02M	39.75%262.05M	72.54%113.32M	25.30%51.57M	40.66%52.94M	2.75%44.22M	0.77%187.51M	28.75%65.68M	2.92%41.16M	-17.81%37.64M
Selling and administrative expenses	33.18%38.68M	32.13%129.43M	35.00%36.74M	39.68%34.47M	22.37%29.18M	30.73%29.05M	13.97%97.95M	19.67%27.22M	18.87%24.68M	9.12%23.84M
Research and development costs	73.57%26.33M	16.20%76.1M	39.35%20.05M	3.77%17.11M	72.25%23.77M	-27.12%15.17M	-34.05%65.49M	-47.54%14.39M	-14.30%16.49M	-42.38%13.8M
Other operating expenses	----	134.82%56.52M	----	----	----	----	2,782.75%24.07M	----	----	----
Operating profit	-47.75%-16.54M	-357.81%-25.2M	-98.66%81K	-123.54%-10.93M	83.72%-3.15M	51.99%-11.2M	106.24%9.77M	116.74%6.05M	251.35%46.41M	52.24%-19.37M
Net non-operating interest income expense
Other net income (expense)	23.69%2.27M	581.88%8.54M	198.36%2.37M	654.04%2.43M	1,759.22%1.92M	5,288.24%1.83M	1,191.75%1.25M	794K	322K	103K
Other non- operating income (expenses)	23.69%2.27M	581.88%8.54M	198.36%2.37M	654.04%2.43M	1,759.22%1.92M	5,288.24%1.83M	1,191.75%1.25M	--794K	--322K	--103K
Income before tax	-52.46%-14.28M	-251.02%-16.65M	-64.19%2.45M	-118.19%-8.5M	93.57%-1.24M	59.79%-9.36M	107.04%11.03M	118.97%6.84M	252.42%46.74M	52.49%-19.27M
Income tax	17.96%3.43M	82.17%-30.74M	-1,057.44%-22.79M	103.02%5.36M	-2,364.11%-16.21M	50.96%2.91M	-12,543.10%-172.34M	753.05%2.38M	-150,203.39%-177.36M	-29.39%716K
Net income	-44.29%-17.7M	-92.32%14.08M	465.73%25.24M	-106.18%-13.86M	174.93%14.97M	51.33%-12.27M	216.11%183.36M	112.28%4.46M	833.67%224.09M	51.93%-19.98M
Net income continuous Operations	-44.29%-17.7M	-92.32%14.08M	465.73%25.24M	-106.18%-13.86M	174.93%14.97M	51.33%-12.27M	216.11%183.36M	112.28%4.46M	833.67%224.09M	51.93%-19.98M
Minority interest income
Net income attributable to the parent company	-44.29%-17.7M	-92.32%14.08M	465.73%25.24M	-106.18%-13.86M	174.93%14.97M	51.33%-12.27M	216.11%183.36M	112.28%4.46M	833.67%224.09M	51.93%-19.98M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-44.29%-17.7M	-92.32%14.08M	465.73%25.24M	-106.18%-13.86M	174.93%14.97M	51.33%-12.27M	216.11%183.36M	112.28%4.46M	833.67%224.09M	51.93%-19.98M
Basic earnings per share	-38.89%-0.25	-92.42%0.2	500.00%0.36	-106.19%-0.2	172.41%0.21	50.00%-0.18	214.78%2.64	111.32%0.06	834.09%3.23	52.46%-0.29
Diluted earnings per share	-38.89%-0.25	-92.31%0.2	483.33%0.35	-106.29%-0.2	172.41%0.21	50.00%-0.18	213.04%2.6	111.32%0.06	822.73%3.18	52.46%-0.29
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall